Download PDF
CC BY-NC-ND 4.0 · Asian J Neurosurg 2019; 14(01): 283-285
DOI: 10.4103/ajns.AJNS_332_17
Case Report

Malignant peripheral nerve sheath tumor: Treat or not treat?

Muhamad Bin Samsuddin
Department of Neurosurgery, Hospital Raja Permaisuri Bainun, Ipoh, Perak
,
Mohamad Bin Omar
Department of Neurosurgery, Hospital Raja Permaisuri Bainun, Ipoh, Perak
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Malignant peripheral nerve sheath tumors (MPNSTs) are uncommon, biologically aggressive soft tissue sarcomas of neural origin that poses tremendous challenges to effective therapy. MPNSTs are among the most challenging mesenchymal malignancies to treat with poor prognosis. They usually affect young and middle-aged adults, tend toward early metastasis, and often demonstrate resistance to chemotherapy. We present a case of a 23-year-old female who initially presented with the right temporal swelling for 1 month associated with constitutional symptom which progressively worsening. The right craniotomy and excision biopsy were done with histopathological examination results suggestive of MPNST. Thorax-abdominal-pelvic computed tomography and magnetic resonance imaging further revealed multiple metastatic lesions involving spine, retroperitoneal, pelvic, chest wall, and lungs. This case illustrates the typical presentation of MPNST with its known poorly outcome.

Key-words:

Malignant peripheral nerve sheath tumors - neurofibromatosis type 1 - prognosis - survival

Financial support and sponsorship

Nil.




Publication History

Article published online:
09 September 2022

© 2019. Asian Congress of Neurological Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Grobmyer SR, Reith JD, Shahlaee A, Bush CH, Hochwald SN. Malignant peripheral nerve sheath tumor: Molecular pathogenesis and current management considerations. J Surg Oncol 2008;97:340-9.
  • 2 Malignant Peripheral Nerve Sheath Tumour; August 2015. Sarcoma UK. Available from: https://www.sarcoma.org.uk/sarcoma-types/malignant-peripheral-nerve-sheath-tumour-mpnst#toc-8. [Last accessed on 2017 May 15].
  • 3 Doorn PF, Molenaar WM, Buter J, Hoekstra HJ. Malignant peripheral nerve sheath tumors in patients with and without neurofibromatosis. Eur J Surg Oncol 1995;21:78-82.
  • 4 Ferner RE, Gutmann DH. International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis. Cancer Res 2002;62:1573-7.
  • 5 Ducatman BS, Scheithauer BW, Piepgras DG, Reiman HM, Ilstrup DM. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer 1986;57:2006-21.
  • 6 Evans DG, Baser ME, McGaughran J, Sharif S, Howard E, Moran A, et al. Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet 2002;39:311-4.
  • 7 Anghileri M, Miceli R, Fiore M, Mariani L, Ferrari A, Mussi C, et al. Malignant peripheral nerve sheath tumors: Prognostic factors and survival in a series of patients treated at a single institution. Cancer 2006;107:1065-74.
  • 8 Zou C, Smith KD, Liu J, Lahat G, Myers S, Wang WL, et al. Clinical, pathological, and molecular variables predictive of malignant peripheral nerve sheath tumor outcome. Ann Surg 2009;249:1014-22.
  • 9 LaFemina J, Qin LX, Moraco NH, Antonescu CR, Fields RC, Crago AM, et al. Oncologic outcomes of sporadic, neurofibromatosis-associated, and radiation-induced malignant peripheral nerve sheath tumors. Ann Surg Oncol 2013;20:66-72.
  • 10 Stucky CC, Johnson KN, Gray RJ, Pockaj BA, Ocal IT, Rose PS, et al. Malignant peripheral nerve sheath tumors (MPNST): The mayo clinic experience. Ann Surg Oncol 2012;19:878-85.
  • 11 Porter DE, Prasad V, Foster L, Dall GF, Birch R, Grimer RJ, et al. Survival in malignant peripheral nerve sheath tumours: A Comparison between sporadic and neurofibromatosis type 1-associated tumours. Sarcoma 2009;2009:756395.
  • 12 Heslin MJ, Cordon-Cardo C, Lewis JJ, Woodruff JM, Brennan MF. Ki-67 detected by MIB-1 predicts distant metastasis and tumor mortality in primary, high grade extremity soft tissue sarcoma. Cancer 1998;83:490-7.
  • 13 Levine EA, Holzmayer T, Bacus S, Mechetner E, Mera R, Bolliger C, et al. Evaluation of newer prognostic markers for adult soft tissue sarcomas. J Clin Oncol 1997;15:3249-57.